Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11464 posts found.

VistaGen’s social anxiety disorder treatment fails to meet primary endpoint in Phase III

July 25, 2022 Sales and Marketing

VistaGen Therapeutics has announced topline data from its Phase III PALISADE-1 trial which shows that PH94B, its nasal spray candidate …
News

Recent hepatitis linked to adeno-associated virus AAV2

July 25, 2022 Sales and Marketing

Recent acute hepatitis cases of unknown origin in children have now been linked to the virus AAV2 in two new …
News

Monkeypox declared global health emergency

July 25, 2022 Sales and Marketing

For the second time in two years, WHO declared a global health emergency, this time for monkeypox. The declaration is …
News

MPs warn NHS in England facing worst staffing crisis in history

July 25, 2022 Sales and Marketing

A recent report by MPs say that the large number of unfilled NHS job vacancies is posing a serious risk …
News

Ghana records first ever suspected cases of Marburg virus disease

July 11, 2022 Sales and Marketing

Health authorities in Ghana have shared that for the first time they have confirmed two fatal cases of the Marburg …
News

WHO and Kenya launch medical emergency hub in Nairobi

July 11, 2022 Sales and Marketing

WHO and the Kenyan government have launched an emergency hub for public health risks in the country’s capital and largest …
News

COVID-19 hospital cases expected to rise

July 4, 2022 Sales and Marketing

The CEO of UKSHA has said that the number of people being admitted to hospital with COVID-19 is expected to …
News

Liver injuries trigger clinical hold on Sanofi’s BTK drug

July 4, 2022 Sales and Marketing

The FDA has placed a partial clinical hold on Sanofi’s Phase III BTK inhibitor trial, following reports of drug-induced liver …
News

Knee replacement NHS policies on patient’s weight worsened health inequalities

July 4, 2022 Sales and Marketing

New research has found that weight/body mass index (BMI) policies introduced by NHS commissioning groups in England are associated with …
News

Long-Term Impact of Prophylactic Orladeyo on Hereditary Angioedema

July 4, 2022 Sales and Marketing

BioCryst Pharmaceuticals have shared new 96-week data from the open-label global randomised Phase III Apex-2 trial, and an independent six …
News

Telehealth clinics still offering abortion pills to people outside their states

June 27, 2022 Sales and Marketing

Telehealth abortion clinics have shared that they are still offering pills to people outside of their states, following the Supreme …
News

China NMPA approves TYVYT for gastric/gastroesophageal junction adenocarcinoma

June 27, 2022 Sales and Marketing

The National Medical Products Administration (NMPA) has approved the supplemental NDA for TYVYT (sintilimab injection) in combination with fluorouracil and …
News

NHS patients could have chance to travel for surgery

June 27, 2022 Sales and Marketing

NHS patients in England, who have been waiting over two years for surgery are being offered hospital treatment in certain …
News

CHMP recommends treatment for adults with chronic inflammatory disease

June 27, 2022 Sales and Marketing

The CHMP has recommended upadacitinib (RINVOQ® 15 mg, once daily) for approval, for the treatment of adults with active non-radiographic …
News

Monkeypox outbreak in Europe: UK guidance recommends close contacts isolate for 21 days

May 23, 2022 Sales and Marketing

The UK Health Security Agency (UKHSA) has released updated guidance on monkeypox now recommending that those who have had “unprotected …
News

Latest content

FDA accepts NDA for Karuna’s schizophrenia treatment

November 30, 2023

Vivos Therapeutics gains FDA 510(k) clearance for sleep apnea treatment device

November 30, 2023

Tolremo doses first patient in phase 1 trial for drug to combat transcriptional cancer drug resistance

November 29, 2023

FDA grants breakthrough device designation to Inflammatix’s TriVerity Acute Infection and Sepsis Test System

November 29, 2023

FDA accepts new drug application for Orexo’s opioid overdose medication

November 28, 2023